Correlation Between Bayer AG and Roche Holding
Can any of the company-specific risk be diversified away by investing in both Bayer AG and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bayer AG and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bayer AG PK and Roche Holding AG, you can compare the effects of market volatilities on Bayer AG and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bayer AG with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bayer AG and Roche Holding.
Diversification Opportunities for Bayer AG and Roche Holding
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bayer and Roche is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Bayer AG PK and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and Bayer AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bayer AG PK are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of Bayer AG i.e., Bayer AG and Roche Holding go up and down completely randomly.
Pair Corralation between Bayer AG and Roche Holding
If you would invest 1,686 in Bayer AG PK on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Bayer AG PK or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Bayer AG PK vs. Roche Holding AG
Performance |
Timeline |
Bayer AG PK |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Roche Holding AG |
Bayer AG and Roche Holding Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bayer AG and Roche Holding
The main advantage of trading using opposite Bayer AG and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bayer AG position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.Bayer AG vs. Novartis AG ADR | Bayer AG vs. Sanofi ADR | Bayer AG vs. AstraZeneca PLC ADR | Bayer AG vs. GlaxoSmithKline PLC ADR |
Roche Holding vs. Novartis AG | Roche Holding vs. AstraZeneca PLC | Roche Holding vs. Roche Holding Ltd | Roche Holding vs. Sanofi ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |